Amniotic membrane transplantation combined with antiviral and steroid therapy for herpes necrotizing stromal keratitis.
暂无分享,去创建一个
[1] N. Theodore,et al. Report of two cases and review of the literature , 2006 .
[2] A. Heiligenhaus,et al. Transplantation of amniotic membrane in murine herpes stromal keratitis modulates matrix metalloproteinases in the cornea. , 2005, Investigative ophthalmology & visual science.
[3] H. Grossniklaus. Multilayer amniotic membrane transplantation in the treatment of corneal perforations. Rodriguez-Ares MT, * Tourino R, Lopez-Valladares MJ, Gude F. Cornea 2004;23:577–583 , 2004 .
[4] Wei Li,et al. How does amniotic membrane work? , 2004, The ocular surface.
[5] C. Bouchard,et al. Amniotic membrane transplantation in the management of severe ocular surface disease: indications and outcomes. , 2004, The ocular surface.
[6] H. Dua,et al. The amniotic membrane in ophthalmology. , 2004, Survey of ophthalmology.
[7] A. Heiligenhaus,et al. Management of acute ulcerative and necrotising herpes simplex and zoster keratitis with amniotic membrane transplantation , 2003 .
[8] A. Heiligenhaus,et al. Matrix metalloproteinases (MMP-2 and 9) and tissue inhibitors of matrix metalloproteinases (TIMP-1 and 2) during the course of experimental necrotizing herpetic keratitis. , 2003, Experimental eye research.
[9] E. Tedeschi-Reiner,et al. Amniotic membrane transplantation for ocular surface reconstruction. , 2002, Collegium antropologicum.
[10] T. Tervo,et al. In Vivo Confocal Microscopy After Herpes Keratitis , 2002, Cornea.
[11] S. Tseng,et al. Amniotic membrane grafts for nontraumatic corneal perforations, descemetoceles, and deep ulcers. , 2002, Ophthalmology.
[12] P. Prabhasawat,et al. Single and multilayer amniotic membrane transplantation for persistent corneal epithelial defect with and without stromal thinning and perforation , 2001, The British journal of ophthalmology.
[13] S. Tseng,et al. Amniotic Membrane Transplantation for Ocular Surface Reconstruction , 2001, Bioscience reports.
[14] A. Heiligenhaus,et al. Improvement of HSV-1 necrotizing keratitis with amniotic membrane transplantation. , 2001, Investigative ophthalmology & visual science.
[15] S. Tseng,et al. Amniotic membrane transplantation for severe neurotrophic corneal ulcers , 2000, The British journal of ophthalmology.
[16] D. H. Ma,et al. Identification of Antiangiogenic and Antiinflammatory Proteins in Human Amniotic Membrane , 2000, Cornea.
[17] N. Koizumi,et al. Growth factor mRNA and protein in preserved human amniotic membrane , 2000 .
[18] A. Heiligenhaus,et al. Macrophage-depletion influences the course of murine HSV-1 keratitis. , 2000, Current eye research.
[19] S. Tseng,et al. Conjunctival epithelial cell differentiation on amniotic membrane. , 1999, Investigative ophthalmology & visual science.
[20] E. Holland,et al. Classification of herpes simplex virus keratitis. , 1999, Cornea.
[21] M. Thiel,et al. Improved impression cytology techniques for the immunopathological diagnosis of superficial viral infections , 1997, The British journal of ophthalmology.
[22] R. Gentz,et al. Cystatin E is a Novel Human Cysteine Proteinase Inhibitor with Structural Resemblance to Family 2 Cystatins* , 1997, The Journal of Biological Chemistry.
[23] S. Tseng,et al. Amniotic membrane transplantation for persistent epithelial defects with ulceration. , 1997, American journal of ophthalmology-glaucoma.
[24] W. Jarosz,et al. Antiviral nonspecific immunity of human placenta at term: possible role of endogenous tumor necrosis factors and interferons. , 1996, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[25] P. McDonnell,et al. The role of smears, cultures, and antibiotic sensitivity testing in the management of suspected infectious keratitis. , 1996, Ophthalmology.
[26] W. Hauck,et al. Herpetic Eye Disease Study: A Controlled Trial of Topical Corticosteroids for Herpes Simplex Stromal Keratitis , 1994 .
[27] A. Heiligenhaus,et al. Exacerbation of murine herpes simplex virus-mediated stromal keratitis by Th2 type T cells. , 1993, Journal of immunology.
[28] D. Pavan-Langston,et al. Herpetic Keratitis: Persistence of Viral Particles Despite Topical and Systemic Antiviral Therapy: Report of Two Cases and Review of the Literature , 1993 .
[29] L. Björck,et al. Cystatin C, a human proteinase inhibitor, blocks replication of herpes simplex virus , 1990, Journal of virology.
[30] Y. Gordon,et al. Evaluation of Immunologlic Tests for the Detection of Ocular Herpes Simplex Virus , 1989 .
[31] T. Liesegang. Epidemiology of ocular herpes simplex. Natural history in Rochester, Minn, 1950 through 1982. , 1989, Archives of ophthalmology.
[32] Y. Gordon,et al. Evaluation of immunologic tests for the detection of ocular herpes simplex virus. , 1989, Ophthalmology.
[33] D. Pavan-Langston,et al. Rapid detection of herpes simplex virus (HSV) antigen in human ocular infections. , 1988, Current eye research.
[34] V. Turk,et al. Cystatin, a protein inhibitor of cysteine proteases alters viral protein cleavages in infected human cells. , 1985, Biochemical and biophysical research communications.
[35] Angela Ready. Perforations. , 1938, California and western medicine.